Keywords: PA، Pseudomonas aeruginosa; CF, cystic fibrosis; PA, Pseudomonas aeruginosa; HPA, hypermutable Pseudomonas aeruginosa; MDR, multi-drug resistant; FEV1%, forced expiratory volume in 1 s; MEF 25–75%, maximal mid-expiratory flow.Cystic fibrosis; Hypermutable; Pseudomonas aeruginosa
مقالات ISI PA، Pseudomonas aeruginosa (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PA، Pseudomonas aeruginosa; NF, nanofiltration; RO, reverse osmosis; PA, Pseudomonas aeruginosa; SA, sodium alginate; BSA, bovine serum albumin; HA, humic acid; EPS, extracellular polymeric substances; OM, organic matter; ATP, adenosine triphosphate; TDC, total direct cell count; SE
Keywords: PA، Pseudomonas aeruginosa; CF, cystic fibrosis; Pa, Pseudomonas aeruginosa; OP, oropharyngeal; BAL, bronchoalveolar lavage; EPIC OBS, Early Pseudomonas Infection Control Observational Study; CFFNPR, CFF National Patient Registry; GEE, generalized estimating equations; ROC, receiver
A cultivation-independent PCR-RFLP assay targeting oprF gene for detection and identification of Pseudomonas spp. in samples from fibrocystic pediatric patients
Keywords: PA، Pseudomonas aeruginosa; Pa, Pseudomonas aeruginosa; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphismCystic fibrosis; oprF; PCR-RFLP; Pseudomonas aeruginosa
Genetic variations in toll-like receptor pathway and lung function decline in Cystic Fibrosis patients
Keywords: PA، Pseudomonas aeruginosa; CF, cystic fibrosis; TLR, toll-like receptor; LBP, lipopolysaccharide binding protein; FEV1, forced expiratory volume in one second; SNP, single nucleotide polymorphisms; NFκB, nuclear factor kappa beta; Pa, Pseudomonas aeruginosa
Role of epithelial mucins during airway infection
Keywords: PA، Pseudomonas aeruginosa; MUC1 mucin; Pseudomonas; Toll-like receptor; Airway infection; Inflammation; Anti-inflammationCT, Cytoplasmic tail; NE, Neutrophil elastase; PA, Pseudomonas aeruginosa; TLR, Toll-like receptor
Causative Pathogen Dictates Optimal Duration of Antimicrobial Therapy for Ventilator-Associated Pneumonia in Trauma Patients
Keywords: PA، Pseudomonas aeruginosa; AB, Acinetobacter baumannii; BAL, bronchoalveolar lavage; CFU, colony-forming units; ENB, Enterobacteriaceae; MR, microbiological resolution; PA, Pseudomonas aeruginosa; SM, Stenotrophomonas maltophilia; VAP, ventilator-associated pneumonia
Molecular Basis of Bacterial Defense against Host Lysozymes: X-ray Structures of Periplasmic Lysozyme Inhibitors PliI and PliC
Keywords: PA، Pseudomonas aeruginosa; lysozyme; PliI; PliC; crystal structure; SAXSPliC, periplasmic lysozyme inhibitor of C-type lysozyme; St, Salmonella typhimurium; MliC, membrane-associated lysozyme inhibitor of C-type lysozyme; Pa, Pseudomonas aeruginosa; Ec, Escherichia coli; PliI, peri
Early Eradication of Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Keywords: PA، Pseudomonas aeruginosa; Pa, Pseudomonas aeruginosa; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulator; BAL, bronchoalveolar lavage; OP, oropharyngeal; PCR, polymerase chain reactionPseudomonas aeruginosa; cystic fibrosis; inhaled tobramycin; eradicat
Real life evaluation of intravenous antibiotic treatment in a paediatric cystic fibrosis centre: Outcome of home therapy is not inferior
Keywords: PA، Pseudomonas aeruginosa; Cystic fibrosis; Lung infection; Intravenous antibiotics; Home therapy; Paediatric; OutcomeCF, cystic fibrosis; TO, treatment observation; IV-AB, intravenous antibiotics; Pa, Pseudomonas aeruginosa; Bc, Burkholderia cepacia; FEV1, forced expiratory volume
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden
Keywords: PA، Pseudomonas aeruginosa; SCFSC, Scandinavian CF Study Consortium; PA, Pseudomonas aeruginosa; CF, cystic fibrosis; PI, pancreatic insufficient; CIE, crossed immunoelectrophoresis; FEV1, forced expiratory volume in one second; CFTR, Cystic fibrosis transmembrane conductance regula
Structure–activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: Alkenyl-amidines as new leads
Keywords: PA، Pseudomonas aeruginosa; o-PA, o-phthaldialdehyde; l-VNIO, N5-(1-iminobut-3-enyl)-l-ornithine; Pa, Pseudomonas aeruginosa; ADMA, Nω,Nω-dimethyl-l-arginine; NMMA, Nω-monomethyl-l-arginine; NO, nitric oxide; DDAH, dimethylarginine dimethylaminohydrolase; NOS, nitric oxide synthase;
Site-directed mutagenesis studies of acetylglutamate synthase delineate the site for the arginine inhibitor
Keywords: PA، Pseudomonas aeruginosa; AAK, amino acid kinase; GNAT, GCN5-related N-acetyltransferase; NAG, N-acetyl-l-glutamate; NAGK, N-acetyl-l-glutamate kinase; NAGS, N-acetyl-l-glutamate synthase; Pa, Pseudomonas aeruginosa; Ec, Escherichia coli; Ng, Neisseria gonorrhoeae; Hu, humanN-acet
Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection
Keywords: PA، Pseudomonas aeruginosa; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane regulator; CI, chronically infected; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PA, Pseudomonas aeruginosa; PE, pulmonary exacerbation; T3, type III
Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis
Keywords: PA، Pseudomonas aeruginosa; bronchiectasis; exacerbations; inflammation; natural history; Pseudomonas aeruginosaCF, cystic fibrosis; CRP, C-reactive protein; ESR, erithrocyte sedimentation rate; HRCT, high-resolution CT; PA, Pseudomonas aeruginosa